More recent data, reported up to 2017, have demonstrated that the cohort aged ≤30 years, who received the universal infant HB vaccination had a 36% reduction in HCC incidence compared with that before the universal HB vaccination [108]. This evidence concerns the gene GSTM1 and hepatocellular carcinoma.